Published in J Infect Dis on July 11, 2005
Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers. PLoS One (2015) 1.43
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol (2007) 1.41
Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol (2007) 1.23
Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells. Antimicrob Agents Chemother (2006) 1.06
HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS One (2012) 0.94
Binding of human milk to pathogen receptor DC-SIGN varies with bile salt-stimulated lipase (BSSL) gene polymorphism. PLoS One (2011) 0.86
Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes. PLoS One (2015) 0.77
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis (2009) 4.48
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin Infect Dis (2008) 4.47
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med (2013) 3.24
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis (2011) 2.88
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS (2010) 2.54
HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr (2005) 1.87
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog (2008) 1.83
Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents. Clin Infect Dis (2008) 1.81
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med (2009) 1.69
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One (2013) 1.69
Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Mol Microbiol (2008) 1.46
Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol (2013) 1.46
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans. J Clin Invest (2008) 1.45
The DEAD-box RNA helicase Vad1 regulates multiple virulence-associated genes in Cryptococcus neoformans. J Clin Invest (2005) 1.44
Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med (2010) 1.43
Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res (2004) 1.43
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol (2007) 1.41
CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence. Infect Immun (2004) 1.36
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons. HIV Clin Trials (2008) 1.32
Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest (2007) 1.32
Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity (2012) 1.28
The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals. J Int Neuropsychol Soc (2005) 1.25
Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One (2013) 1.24
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies. HIV Clin Trials (2007) 1.21
Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc (2004) 1.19
Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS (2011) 1.19
A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans. Mol Microbiol (2003) 1.19
Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J Biol Chem (2007) 1.11
Role of a VPS41 homologue in starvation response, intracellular survival and virulence of Cryptococcus neoformans. Mol Microbiol (2006) 1.11
Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination of virulent Cryptococcus neoformans in mice. PLoS One (2012) 1.05
Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching. J Med Chem (2011) 1.01
The Hsp70 member, Ssa1, acts as a DNA-binding transcriptional co-activator of laccase in Cryptococcus neoformans. Mol Microbiol (2006) 1.00
Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1. Pharmacotherapy (2004) 1.00
Copper-mediated reversal of defective laccase in a Deltavph1 avirulent mutant of Cryptococcus neoformans. Mol Microbiol (2003) 0.99
Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906. J Acquir Immune Defic Syndr (2013) 0.98
Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis (2005) 0.98
Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice. Infect Immun (2006) 0.97
Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin Immunol (2004) 0.97
Fungal Infections of the Central Nervous System. Continuum (Minneap Minn) (2015) 0.96
Role of CTR4 in the Virulence of Cryptococcus neoformans. MBio (2012) 0.96
TLR2-mediated cell stimulation in bacterial vaginosis. J Reprod Immunol (2007) 0.95
Mucosal HIV-binding antibody and neutralizing activity in high-risk HIV-uninfected female participants in a trial of HIV-vaccine efficacy. J Infect Dis (2007) 0.95
Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase. ChemMedChem (2008) 0.94
Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant. Infect Immun (2007) 0.93
A novel specificity protein 1 (SP1)-like gene regulating protein kinase C-1 (Pkc1)-dependent cell wall integrity and virulence factors in Cryptococcus neoformans. J Biol Chem (2011) 0.93
Laccase expression in murine pulmonary Cryptococcus neoformans infection. Infect Immun (2005) 0.92
Role of homoserine transacetylase as a new target for antifungal agents. Antimicrob Agents Chemother (2007) 0.90
Intersection of fungal fitness and virulence in Cryptococcus neoformans. FEMS Yeast Res (2006) 0.89
The role of laccase in prostaglandin production by Cryptococcus neoformans. Mol Microbiol (2008) 0.89
Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans. MBio (2013) 0.88
Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans. J Infect Chemother (2011) 0.87
Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection. PLoS One (2013) 0.86
A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans. J Biomol Screen (2013) 0.85
The diverse roles of autophagy in medically important fungi. Autophagy (2008) 0.85
Mating pheromone in Cryptococcus neoformans is regulated by a transcriptional/degradative "futile" cycle. J Biol Chem (2010) 0.85
HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906. J Urban Health (2015) 0.83
Microevolution during serial mouse passage demonstrates FRE3 as a virulence adaptation gene in Cryptococcus neoformans. MBio (2014) 0.82
Anthrax lethal factor activates K(+) channels to induce IL-1β secretion in macrophages. J Immunol (2011) 0.81
Susceptibility of intact germinating Arabidopsis thaliana to human fungal pathogens Cryptococcus neoformans and C. gattii. Appl Environ Microbiol (2013) 0.81
Implementing universal oral HIV screening in an urban emergency department-do demographic characteristics impact acceptance of testing? Clin Infect Dis (2010) 0.80
Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens. PLoS One (2013) 0.80
Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant. Microbiology (2010) 0.80
A high-throughput screening assay for assessing the viability of Cryptococcus neoformans under nutrient starvation conditions. Anal Bioanal Chem (2013) 0.80
Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008. AIDS Res Treat (2012) 0.79
A copper hyperaccumulation phenotype correlates with pathogenesis in Cryptococcus neoformans. Metallomics (2013) 0.79
Cryptococcus neoformans growth and protection from innate immunity are dependent on expression of a virulence-associated DEAD-box protein, Vad1. Infect Immun (2012) 0.79
Mucosal innate immune factors in secretions from high-risk individuals immunized with a bivalent gp120 vaccine. AIDS Res Hum Retroviruses (2007) 0.79
Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells. J Gen Virol (2008) 0.78
IL-22 levels are associated with Trichomonas vaginalis infection in the lower genital tract. Am J Reprod Immunol (2013) 0.78
Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery. AIDS Res Hum Retroviruses (2014) 0.77
Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med (2011) 0.77
Viable Mycobacterium avium is required for the majority of human immunodeficiency virus-induced upregulation in monocytoid cells. J Med Microbiol (2003) 0.77
Interferon-gamma receptors in HIV-1 infection. AIDS Res Hum Retroviruses (2008) 0.77
Analysis of autophagy during infections of Cryptococcus neoformans. Methods Enzymol (2008) 0.76
Multiplex meta-analysis of RNA expression to identify genes with variants associated with immune dysfunction. J Am Med Inform Assoc (2012) 0.76
'Popping the clutch': novel mechanisms regulating sexual development in Cryptococcus neoformans. Mycopathologia (2011) 0.76
Treatment options in Invasive Aspergillosis. Curr Treat Options Infect Dis (2014) 0.75
Advancing translational immunology in HIV-associated cryptococcal meningitis. J Infect Dis (2013) 0.75
The promise of immunogenomics at the bedside: genetic risk of intra-abdominal candidiasis*. Crit Care Med (2014) 0.75
Mycobacterium conceptionense Pneumonitis in Patient with HIV/AIDS. Emerg Infect Dis (2019) 0.75
Sexually Transmitted Disease Testing of Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: Room for Improvement. Sex Transm Dis (2017) 0.75
Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr (2017) 0.75
Pathogen diversity and adaptation to the host: applications to clinical genomics. Future Microbiol (2007) 0.75
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients. Antivir Ther (2006) 0.75